Please login to the form below
ViroPharma
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.
WCG expands London office
The agency now serves the international communications needs of many multi-national companies, including Pfizer, Boston Scientific, Dendreon, Genomic Health and ViroPharma.
EMA considers two epilepsy treatments
The European Medicines Agency has accepted for review the marketing authorisation application for Eisai's perampanel while the agency's CHMP has recommended the approval of ViroPharma's Buccolam. ... Meanwhile the Committee for Medicinal Products for
EC gives ViroPharma Cinryze go-ahead
The European Commission has granted ViroPharma Centralised Marketing Authorisation for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema. ... The European Commission has granted ViroPharma Centralised Marketing
Optimer antibiotic approved
difficile-associated diarrhoea.". In clinical trials, Dificid worked as well as ViroPharma's Vancocin (vancomycin) in curing CDAD and was better than vancomycin at preventing recurrence of infection.
FDA reviewers support Optimer antibiotic
In the documents, which are intended to help guide the advisory panel members, the FDA staff reviewers said fidaxomicin worked as well as ViroPharma's Vancocin (vancomycin) in curing C.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
-
Account Manager
-
Competitive salary with bonus and benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Home or away: where next for pharmaceutical symposia?
- Gilead’s Veklury receives FDA approval for non-hospitalised high-risk patients to treat COVID-19
- FDA grants priority review for Roche’s Evrysdi for spinal muscular atrophy in babies
- FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- Pfizer’s Paxlovid receives positive opinion from CHMP
- Moderna begins phase 2 trial of Omicron-specific booster
- Expanding Access to High-Quality Healthcare
- FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
- Janssen’s Tremfya receives positive results for active psoriatic arthritis
- ARISE - a strategic healthcare communication planning process from Bedrock
- Why pharma must get smart in its approach to customer engagement
- An EU emergency health fund to limit the impact of future crises
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- FDA approval for OTC delayed release omeprazole in US
- PM announces plans to lift England’s COVID-19 restrictions
- What challenges still face clinical trial recruitment and retention?
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
Latest intelligence
- Personalised medicine: driving a need for greater diversity in clinical trials
- Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
